Nova Patents
IS7337A

Nicotinamide derivates useful as P38 inhibitors

Abstract

Compounds of formula (I): are inhibitors of p38 kinase and are useful in the treatment of conditions or disease states mediated by p38 kinase activity or mediated by cytokines produced by the activity of p38.

Term

Term ended

Projected expiry passed 28 June 2024, 2.2 years ago.

  1. Priority
  2. Filed and published
  3. Projected expiry
  4. Today

64 members in 27 offices

This recordMember, by publication datePriority claim17 more offices are in the list below

Priority claims11

Priority claims
DocumentOfficeKindDate
0203301United KingdomA
0203301United KingdomA
0225385United KingdomA
0225385United KingdomA
0300554United KingdomW
0300554United KingdomW
GB02033017A–––
GB20020003301–––
GB20020025385–––
PCTGB0300554–––
WO2003GB00554–––

Members64

Family members, oldest first
DocumentOfficeKind
GB0203301D0United KingdomD0
GB0225385D0United KingdomD0
CA2474192A1CanadaA1
WO03068747A1World Intellectual Property Organization (WIPO)A1
AU2003207298A1AustraliaA1
IS7337AThis recordIcelandA
NO20043176LNorwayL
KR20040082425ARepublic of KoreaA
MXPA04007838AMexicoA
EP1474395A1European Patent Office (EPO)A1
BR0307351ABrazilA
RU2004120553ARussian FederationA
CN1633416AChinaA
HK1070896A1Hong Kong, ChinaA1
JP2005519932AJapanA
PL372628A1PolandA1
US2005176964A1United States of AmericaA1
ZA200405602BSouth AfricaB
NZ533865ANew ZealandA
CO5611147A2ColombiaA2
US7125898B2United States of AmericaB2
US2006264479A1United States of AmericaA1
US2006276516A1United States of AmericaA1
EP1474395B1European Patent Office (EPO)B1
RU2309951C2Russian FederationC2
AT375980TAustriaT
DE60316913D1GermanyD1
EP1864975A2European Patent Office (EPO)A2
PT1474395EPortugalE
EP1864975A3European Patent Office (EPO)A3
DK1474395T3DenmarkT3
CN100369898CChinaC
SI1474395T1SloveniaT1
ES2295553T3SpainT3
HK1113056A1Hong Kong, ChinaA1
DE60316913T2GermanyT2
US7514456B2United States of AmericaB2
NO327418B1NorwayB1
IS2520BIcelandB
AU2003207298B2AustraliaB2
US7709506B2United States of AmericaB2
JP2010111699AJapanA
JP4472349B2JapanB2
IL163090AIsraelA
US2010215652A1United States of AmericaA1
US2010215661A1United States of AmericaA1
EP1864975B1European Patent Office (EPO)B1
AT485275TAustriaT
DE60334651D1GermanyD1
EP2258687A1European Patent Office (EPO)A1
PT1864975EPortugalE
DK1864975T3DenmarkT3
SI1864975T1SloveniaT1
ES2352297T3SpainT3
CA2474192CCanadaC
KR101058292B1Republic of KoreaB1
US8252818B2United States of AmericaB2
EP2258687B1European Patent Office (EPO)B1
PL212910B1PolandB1
ES2400486T3SpainT3
US8575204B2United States of AmericaB2
CY1111083T1CyprusT1
BRPI0307351B1BrazilB1
BRPI0307351B8BrazilB8